001     1037884
005     20250203124509.0
024 7 _ |a 10.26434/chemrxiv-2023-1d5w8
|2 doi
024 7 _ |a 10.1002/minf.202300262
|2 doi
024 7 _ |a 10.34734/FZJ-2025-01027
|2 datacite_doi
024 7 _ |a 37833243
|2 pmid
024 7 _ |a WOS:001100903100001
|2 WOS
037 _ _ |a FZJ-2025-01027
082 _ _ |a 530
100 1 _ |a Schimunek, Johannes
|0 0000-0002-1372-8290
|b 0
245 _ _ |a A community effort to discover small molecule SARS-CoV-2 inhibitors
260 _ _ |a Weinheim
|c 2024
|b Wiley-VCH-Verl.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1738060333_6608
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The COVID-19 pandemic continues to pose a substantial threat to human lives and is likely to do so for years to come. Despite the availability of vaccines, searching for efficient small-molecule drugs that are widely available, including in low- and middle-income countries, is an ongoing challenge. In this work, we report the results of an open science community effort, the “Billion molecules against COVID-19 challenge”, to identify small-molecule inhibitors against SARS-CoV-2 or relevant human receptors. Participating teams used a wide variety of computational methods to screen a minimum of 1 billion virtual molecules against 6 protein targets. Overall, 31 teams participated, and they suggested a total of 639,024 molecules, which were subsequently ranked to find ‘consensus compounds’. The organizing team coordinated with various contract research organizations (CROs) and collaborating institutions to synthesize and test 878 compounds for biological activity against proteases (Nsp5, Nsp3, TMPRSS2), nucleocapsid N, RdRP (only the Nsp12 domain), and (alpha) spike protein S. Overall, 27 compounds with weak inhibition/binding were experimentally identified by binding-, cleavage-, and/or viral suppression assays and are presented here. Open science approaches such as the one presented here contribute to the knowledge base of future drug discovery efforts in finding better SARS-CoV-2 treatments.
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Seidl, Philipp
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Elez, Katarina
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Hempel, Tim
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Le, Tuan
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Noé, Frank
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Olsson, Simon
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Raich, Lluís
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Winter, Robin
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Gokcan, Hatice
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Gusev, Filipp
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Gutkin, Evgeny M.
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Isayev, Olexandr
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Kurnikova, Maria G.
|0 0000-0002-8010-8374
|b 13
700 1 _ |a Narangoda, Chamali H.
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Zubatyuk, Roman
|0 P:(DE-HGF)0
|b 15
700 1 _ |a Bosko, Ivan P.
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Furs, Konstantin V.
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Karpenko, Anna D.
|0 P:(DE-HGF)0
|b 18
700 1 _ |a Kornoushenko, Yury V.
|0 P:(DE-HGF)0
|b 19
700 1 _ |a Shuldau, Mikita
|0 P:(DE-HGF)0
|b 20
700 1 _ |a Yushkevich, Artsemi
|0 P:(DE-HGF)0
|b 21
700 1 _ |a Benabderrahmane, Mohammed B.
|0 P:(DE-HGF)0
|b 22
700 1 _ |a Bousquet-Melou, Patrick
|0 P:(DE-HGF)0
|b 23
700 1 _ |a Bureau, Ronan
|0 P:(DE-HGF)0
|b 24
700 1 _ |a Charton, Beatrice
|0 P:(DE-HGF)0
|b 25
700 1 _ |a Cirou, Bertrand C.
|0 P:(DE-HGF)0
|b 26
700 1 _ |a Gil, Gérard
|0 P:(DE-HGF)0
|b 27
700 1 _ |a Allen, William J.
|0 P:(DE-HGF)0
|b 28
700 1 _ |a Sirimulla, Suman
|0 P:(DE-HGF)0
|b 29
700 1 _ |a Watowich, Stanley
|0 P:(DE-HGF)0
|b 30
700 1 _ |a Antonopoulos, Nick A.
|0 P:(DE-HGF)0
|b 31
700 1 _ |a Epitropakis, Nikolaos E.
|0 P:(DE-HGF)0
|b 32
700 1 _ |a Krasoulis, Agamemnon K.
|0 P:(DE-HGF)0
|b 33
700 1 _ |a Pitsikalis, Vassilis P.
|0 P:(DE-HGF)0
|b 34
700 1 _ |a Theodorakis, Stavros T.
|0 P:(DE-HGF)0
|b 35
700 1 _ |a Kozlovskii, Igor
|0 P:(DE-HGF)0
|b 36
700 1 _ |a Maliutin, Anton
|0 P:(DE-HGF)0
|b 37
700 1 _ |a Medvedev, Alexander
|0 P:(DE-Juel1)156409
|b 38
700 1 _ |a Popov, Petr
|0 P:(DE-HGF)0
|b 39
700 1 _ |a Zaretckii, Mark
|0 P:(DE-HGF)0
|b 40
700 1 _ |a Eghbal-zadeh, Hamid
|0 P:(DE-HGF)0
|b 41
700 1 _ |a Halmich, Christina
|0 P:(DE-HGF)0
|b 42
700 1 _ |a Hochreiter, Sepp
|0 P:(DE-HGF)0
|b 43
700 1 _ |a Mayr, Andreas
|0 P:(DE-HGF)0
|b 44
700 1 _ |a Ruch, Peter
|0 P:(DE-HGF)0
|b 45
700 1 _ |a Widrich, Michael
|0 P:(DE-HGF)0
|b 46
700 1 _ |a Berenger, Francois
|0 P:(DE-HGF)0
|b 47
700 1 _ |a Kumar, Ashutosh
|0 P:(DE-HGF)0
|b 48
700 1 _ |a Yamanishi, Yoshihiro
|0 P:(DE-HGF)0
|b 49
700 1 _ |a Zhang, Kam Y. J.
|0 P:(DE-HGF)0
|b 50
700 1 _ |a Bengio, Emmanuel
|0 P:(DE-HGF)0
|b 51
700 1 _ |a Bengio, Yoshua
|0 P:(DE-HGF)0
|b 52
700 1 _ |a Jain, Moksh J.
|0 P:(DE-HGF)0
|b 53
700 1 _ |a Korablyov, Maksym
|0 P:(DE-HGF)0
|b 54
700 1 _ |a Liu, Cheng-Hao
|0 P:(DE-Juel1)166375
|b 55
700 1 _ |a Marcou, Gilles
|0 P:(DE-HGF)0
|b 56
700 1 _ |a Glaab, Enrico
|0 P:(DE-HGF)0
|b 57
700 1 _ |a Barnsley, Kelly
|0 P:(DE-HGF)0
|b 58
700 1 _ |a Iyengar, Suhasini M.
|0 P:(DE-HGF)0
|b 59
700 1 _ |a Ondrechen, Mary Jo
|0 P:(DE-HGF)0
|b 60
700 1 _ |a Haupt, V. Joachim
|0 P:(DE-HGF)0
|b 61
700 1 _ |a Kaiser, Florian
|0 P:(DE-HGF)0
|b 62
700 1 _ |a Schroeder, Michael
|0 P:(DE-HGF)0
|b 63
700 1 _ |a Pugliese, Luisa
|0 P:(DE-HGF)0
|b 64
700 1 _ |a Albani, Simone
|0 P:(DE-Juel1)181061
|b 65
|u fzj
700 1 _ |a Athanasiou, Christina
|0 P:(DE-HGF)0
|b 66
700 1 _ |a Beccari, Andrea
|0 P:(DE-HGF)0
|b 67
700 1 _ |a Carloni, Paolo
|0 P:(DE-Juel1)145614
|b 68
|u fzj
700 1 _ |a D'Arrigo, Giulia
|0 P:(DE-HGF)0
|b 69
700 1 _ |a Gianquinto, Eleonora
|0 P:(DE-HGF)0
|b 70
700 1 _ |a Goßen, Jonas
|0 P:(DE-HGF)0
|b 71
700 1 _ |a Hanke, Anton
|0 P:(DE-HGF)0
|b 72
700 1 _ |a Joseph, Benjamin P.
|0 P:(DE-Juel1)179040
|b 73
|u fzj
700 1 _ |a Kokh, Daria B.
|0 P:(DE-HGF)0
|b 74
700 1 _ |a Kovachka, Sandra
|0 P:(DE-HGF)0
|b 75
700 1 _ |a Manelfi, Candida
|0 P:(DE-HGF)0
|b 76
700 1 _ |a Mukherjee, Goutam
|0 P:(DE-HGF)0
|b 77
700 1 _ |a Muñiz-Chicharro, Abraham
|0 P:(DE-HGF)0
|b 78
700 1 _ |a Musiani, Francesco
|0 P:(DE-HGF)0
|b 79
700 1 _ |a Nunes-Alves, Ariane
|0 P:(DE-HGF)0
|b 80
700 1 _ |a Paiardi, Giulia
|0 P:(DE-HGF)0
|b 81
700 1 _ |a Rossetti, Giulia
|0 P:(DE-Juel1)145921
|b 82
|u fzj
700 1 _ |a Sadiq, S. Kashif
|0 P:(DE-HGF)0
|b 83
700 1 _ |a Spyrakis, Francesca
|0 P:(DE-HGF)0
|b 84
700 1 _ |a Talarico, Carmine
|0 P:(DE-HGF)0
|b 85
700 1 _ |a Tsengenes, Alexandros
|0 P:(DE-HGF)0
|b 86
700 1 _ |a Wade, Rebecca C.
|0 P:(DE-HGF)0
|b 87
700 1 _ |a Copeland, Conner
|0 P:(DE-HGF)0
|b 88
700 1 _ |a Gaiser, Jeremiah
|0 P:(DE-HGF)0
|b 89
700 1 _ |a Olson, Daniel R.
|0 P:(DE-HGF)0
|b 90
700 1 _ |a Roy, Amitava
|0 P:(DE-HGF)0
|b 91
700 1 _ |a Venkatraman, Vishwesh
|0 P:(DE-HGF)0
|b 92
700 1 _ |a Wheeler, Travis J.
|0 P:(DE-HGF)0
|b 93
700 1 _ |a Arthanari, Haribabu
|0 P:(DE-HGF)0
|b 94
700 1 _ |a Blaschitz, Klara
|0 P:(DE-HGF)0
|b 95
700 1 _ |a Cespugli, Marco
|0 P:(DE-HGF)0
|b 96
700 1 _ |a Durmaz, Vedat
|0 P:(DE-HGF)0
|b 97
700 1 _ |a Fackeldey, Konstantin
|0 P:(DE-HGF)0
|b 98
700 1 _ |a Fischer, Patrick D.
|0 P:(DE-HGF)0
|b 99
700 1 _ |a Gorgulla, Christoph
|0 P:(DE-HGF)0
|b 100
700 1 _ |a Gruber, Christian
|0 P:(DE-HGF)0
|b 101
700 1 _ |a Gruber, Karl
|0 P:(DE-HGF)0
|b 102
700 1 _ |a Hetmann, Michael
|0 P:(DE-HGF)0
|b 103
700 1 _ |a Kinney, Jamie E.
|0 P:(DE-HGF)0
|b 104
700 1 _ |a Padmanabha Das, Krishna M.
|0 P:(DE-HGF)0
|b 105
700 1 _ |a Pandita, Shreya
|0 P:(DE-HGF)0
|b 106
700 1 _ |a Singh, Amit
|0 P:(DE-HGF)0
|b 107
700 1 _ |a Steinkellner, Georg
|0 P:(DE-HGF)0
|b 108
700 1 _ |a Tesseyre, Guilhem
|0 P:(DE-HGF)0
|b 109
700 1 _ |a Wagner, Gerhard
|0 P:(DE-HGF)0
|b 110
700 1 _ |a Wang, Zi-Fu
|0 P:(DE-HGF)0
|b 111
700 1 _ |a Yust, Ryan J.
|0 P:(DE-HGF)0
|b 112
700 1 _ |a Druzhilovskiy, Dmitry S.
|0 P:(DE-HGF)0
|b 113
700 1 _ |a Filimonov, Dmitry A.
|0 P:(DE-HGF)0
|b 114
700 1 _ |a Pogodin, Pavel V.
|0 P:(DE-HGF)0
|b 115
700 1 _ |a Poroikov, Vladimir
|0 P:(DE-HGF)0
|b 116
700 1 _ |a Rudik, Anastassia V.
|0 P:(DE-HGF)0
|b 117
700 1 _ |a Stolbov, Leonid A.
|0 P:(DE-HGF)0
|b 118
700 1 _ |a Veselovsky, Alexander V.
|0 P:(DE-HGF)0
|b 119
700 1 _ |a De Rosa, Maria
|0 P:(DE-HGF)0
|b 120
700 1 _ |a De Simone, Giada
|0 P:(DE-HGF)0
|b 121
700 1 _ |a Gulotta, Maria R.
|0 P:(DE-HGF)0
|b 122
700 1 _ |a Lombino, Jessica
|0 P:(DE-HGF)0
|b 123
700 1 _ |a Mekni, Nedra
|0 P:(DE-HGF)0
|b 124
700 1 _ |a Perricone, Ugo
|0 P:(DE-HGF)0
|b 125
700 1 _ |a Casini, Arturo
|0 P:(DE-HGF)0
|b 126
700 1 _ |a Embree, Amanda
|0 P:(DE-HGF)0
|b 127
700 1 _ |a Gordon, D. Benjamin
|0 P:(DE-HGF)0
|b 128
700 1 _ |a Lei, David
|0 P:(DE-HGF)0
|b 129
700 1 _ |a Pratt, Katelin
|0 P:(DE-HGF)0
|b 130
700 1 _ |a Voigt, Christopher A.
|0 P:(DE-HGF)0
|b 131
700 1 _ |a Chen, Kuang-Yu
|0 P:(DE-HGF)0
|b 132
700 1 _ |a Jacob, Yves
|0 P:(DE-HGF)0
|b 133
700 1 _ |a Krischuns, Tim
|0 P:(DE-HGF)0
|b 134
700 1 _ |a Lafaye, Pierre
|0 P:(DE-HGF)0
|b 135
700 1 _ |a Zettor, Agnès
|0 P:(DE-HGF)0
|b 136
700 1 _ |a Rodríguez, M. Luis
|0 P:(DE-Juel1)137091
|b 137
700 1 _ |a White, Kris M.
|0 P:(DE-HGF)0
|b 138
700 1 _ |a Fearon, Daren
|0 P:(DE-HGF)0
|b 139
700 1 _ |a Von Delft, Frank
|0 P:(DE-HGF)0
|b 140
700 1 _ |a Walsh, Martin A.
|0 P:(DE-HGF)0
|b 141
700 1 _ |a Horvath, Dragos
|0 P:(DE-HGF)0
|b 142
700 1 _ |a Brooks III, Charles L.
|0 P:(DE-HGF)0
|b 143
700 1 _ |a Falsafi, Babak
|0 P:(DE-HGF)0
|b 144
700 1 _ |a Ford, Bryan
|0 P:(DE-HGF)0
|b 145
700 1 _ |a García-Sastre, Adolfo
|0 P:(DE-HGF)0
|b 146
700 1 _ |a Lee, Sang Yup
|0 P:(DE-HGF)0
|b 147
700 1 _ |a Naffakh, Nadia
|0 P:(DE-HGF)0
|b 148
700 1 _ |a Varnek, Alexandre
|0 P:(DE-HGF)0
|b 149
700 1 _ |a Klambauer, Günter
|0 P:(DE-HGF)0
|b 150
700 1 _ |a Hermans, Thomas M.
|0 P:(DE-HGF)0
|b 151
|e Corresponding author
773 _ _ |a 10.1002/minf.202300262
|g Vol. 43, no. 1, p. e202300262
|0 PERI:(DE-600)2537668-8
|n 1
|p e202300262
|t Molecular informatics
|v 43
|y 2024
|x 1868-1743
856 4 _ |u https://juser.fz-juelich.de/record/1037884/files/Molecular%20Informatics%20-%202023%20-%20Schimunek%20-%20A%20community%20effort%20in%20SARS%E2%80%90CoV%E2%80%902%20drug%20discovery.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:1037884
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 65
|6 P:(DE-Juel1)181061
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 68
|6 P:(DE-Juel1)145614
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 73
|6 P:(DE-Juel1)179040
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 82
|6 P:(DE-Juel1)145921
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-20
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2024-12-20
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-20
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-20
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-20
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-9-20140121
|k INM-9
|l Computational Biomedicine
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-9-20140121
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21